Watch to learn more about the research from Dr. Pickering

Novel biomarker appears predictive of outcome in patients with HPV-related head and neck cancers

Curtis Pickering

Gene signature may allow clinicians to better stratify patients and reduce treatment intensity to lower side effectshuman papillomavirus (HPV) in head and neck cancers, researchers at The University of Texas MD Anderson Cancer Center have discovered a gene signature associated with treatment response and survival in patients. Rather than simply classifying tumors as HPV-positive or HPV-negative, this biomarker may one day enable clinicians to better predict patient outcomes, ultimately allowing for reduced treatment intensity to minimize severe side effects. […]